CapEx News

Project News,Updates,Bids & Tenders for Consultants,EPC Contactors,Industrial Suppliers & Service Providers

Home   »   CapEx-News   »  

Odisha's first vaccine manufacturing plant to start production by May

Infrastructure  -  Feb 19,2024  - 

Commercial production at the Sapigen Biologix vaccine plant in Odisha, the first such facility in the state, will commence by May this year, officials said. Chairman 5T and Nabin Odisha VK Pandian visited the facility.

The plant at the Biotech Park in Andharua will have the capacity to produce 2.4 crore doses of different vaccines per day. At full capacity, this facility will be the biggest vaccine-producing plant in the country, the Chief Minister’s Office (CMO) said in a statement.

Pandian visited all the sub-units and interacted with the management and employees. He instructed state government agencies to assist in the commissioning of the plant within the next 3 months.

It is expected to produce over 15 vaccines for various diseases, including cholera and malaria. The Rs 1,500-crore vaccine plant will create direct employment for 1,500 people, with most of them being local recruits, the CMO said.

The variety of vaccines produced in Bhubaneswar will be supplied to many parts of the world, it added.


 

Company :